Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: Positive correlation with disease severity
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 178 (1-2), 156-160
- https://doi.org/10.1016/j.jneuroim.2006.05.026
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosisBrain, 2005
- Interleukin-17: a mediator of inflammatory responsesCellular and Molecular Life Sciences, 2004
- Low leucocyte myeloperoxidase activity in patients with multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Interleukin‐17 in rheumatoid arthritis: If T cells were to contribute to inflammation and destruction through synergyArthritis & Rheumatism, 2003
- Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet’s diseaseJournal of the Neurological Sciences, 2000
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJCI Insight, 1999
- Western versus asian types of multiple sclerosis: Immunogenetically and clinically distinct disordersAnnals of Neurology, 1996
- Serum selenium concentration, glutathione peroxidase activity and lipid peroxides in a co-twin control study on multiple sclerosisJournal of the Neurological Sciences, 1989
- Erythrocyte antioxidant enzymes in multiple sclerosis and the effect of hyperbaric oxygenNeurochemical Research, 1984
- Rating neurologic impairment in multiple sclerosisNeurology, 1983